Weiguo Ye
CIK: 0001985496
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GYRE THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (37 total)
- Jun 18, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct3K shares at avg. $6.35$19K - Jun 18, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct3K shares at avg. $0.75$2K - Jun 11, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct2.8K shares at avg. $0.75$2K - Jun 11, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct2.8K shares at avg. $6.17$17K - Jun 10, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct5K shares at avg. $6.24$31K - Jun 10, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct5K shares at avg. $0.75$4K - Jun 10, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct6.4K shares at avg. $6.21$40K - Jun 10, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct6.4K shares at avg. $0.75$5K - Jun 9, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct3K shares at avg. $6.15$18K - Jun 9, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct3K shares at avg. $0.75$2K - Jun 9, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct14.5K shares at avg. $0.75$11K - Jun 9, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct14.5K shares at avg. $6.14$89K - Jun 5, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct15.4K shares at avg. $6.40$99K - Jun 5, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct15.4K shares at avg. $0.75$12K - Jun 4, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct19.6K shares at avg. $0.75$15K - Jun 4, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct19.6K shares at avg. $6.13$120K - May 26, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct4K shares at avg. $0.75$3K - May 26, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct4K shares at avg. $6.10$24K - May 22, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct3.5K shares at avg. $0.75$3K - May 22, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct3.5K shares at avg. $6.08$21K - May 21, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct12.8K shares at avg. $0.75$10K - May 21, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct12.8K shares at avg. $6.15$79K - May 20, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct9.4K shares at avg. $0.75$7K - May 20, 2026GYRE
GYRE THERAPEUTICS, INC.
Sale(S)Direct9.4K shares at avg. $6.15$58K - May 19, 2026GYRE
GYRE THERAPEUTICS, INC.
Exercise(M)Direct9.1K shares at avg. $0.75$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 3,000 | $6.35 | $19,050 | Direct |
| Jun 18, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 3,000 | $0.75 | $2,250 | Direct |
| Jun 11, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 2,800 | $0.75 | $2,100 | Direct |
| Jun 11, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 2,800 | $6.17 | $17,276 | Direct |
| Jun 10, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 5,000 | $6.24 | $31,200 | Direct |
| Jun 10, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 5,000 | $0.75 | $3,750 | Direct |
| Jun 10, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 6,418 | $6.21 | $39,856 | Direct |
| Jun 10, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 6,418 | $0.75 | $4,814 | Direct |
| Jun 9, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 3,000 | $6.15 | $18,450 | Direct |
| Jun 9, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 3,000 | $0.75 | $2,250 | Direct |
| Jun 9, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 14,500 | $0.75 | $10,875 | Direct |
| Jun 9, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 14,500 | $6.14 | $89,030 | Direct |
| Jun 5, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 15,401 | $6.40 | $98,566 | Direct |
| Jun 5, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 15,401 | $0.75 | $11,551 | Direct |
| Jun 4, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 19,575 | $0.75 | $14,681 | Direct |
| Jun 4, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 19,575 | $6.13 | $119,995 | Direct |
| May 26, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 4,000 | $0.75 | $3,000 | Direct |
| May 26, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 4,000 | $6.10 | $24,400 | Direct |
| May 22, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 3,500 | $0.75 | $2,625 | Direct |
| May 22, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 3,500 | $6.08 | $21,280 | Direct |
| May 21, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 12,820 | $0.75 | $9,615 | Direct |
| May 21, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 12,820 | $6.15 | $78,843 | Direct |
| May 20, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 9,400 | $0.75 | $7,050 | Direct |
| May 20, 2026 | GYRE GYRE THERAPEUTICS, INC. | Sale(S) | 9,400 | $6.15 | $57,810 | Direct |
| May 19, 2026 | GYRE GYRE THERAPEUTICS, INC. | Exercise(M) | 9,120 | $0.75 | $6,840 | Direct |
1-25 of 37 transactions
About Ye Weiguo
Ye Weiguo (SEC CIK 0001985496) files insider reports with the SEC as Chief Operating Officer of GYRE THERAPEUTICS, INC. (GYRE).
Signal8 holds 11 ownership filings by Ye Weiguo, all Form 4s, filed between Mar 11, 2025 and Jun 22, 2026. Those filings report 37 transactions, from Mar 7, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ye Weiguo's filings is in SAN DIEGO, CA.
Recent filings by Ye Weiguo
- Jun 18, 2026: Open-market sale of GYRE shares (Form 4, code S).
- Jun 18, 2026: Option exercise of GYRE shares (Form 4, code M).
- Jun 11, 2026: Option exercise of GYRE shares (Form 4, code M).
- Jun 11, 2026: Open-market sale of GYRE shares (Form 4, code S).
- Jun 10, 2026: Open-market sale of GYRE shares (Form 4, code S).
Other insiders filing for GYRE THERAPEUTICS, INC. (GYRE)
- Weston Claire, Director
- Kirkby Maxwell, Director
- Bergmann Joshua Benjamin, GC and Corporate Secretary
- Luo Ying, Chief Executive Officer
- Zhang Ping, Director
- Wang Jialiang (NMN), EVP, General Manager